Please assess the completion status of the following clinical trial:

Trial Title: Yoga in Treating Sleep Disturbance in Cancer Survivors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of any type of cancer~* More than 1 primary cancer allowed~* Has undergone and completed all forms of standard treatment (surgery, chemotherapy, radiation therapy) within the past 2 to 24 months~* Patients can be on hormones such as Tamoxifen, or monoclonal antibodies like Herceptin~* Persistent sleep disturbance, as indicated by a response of ≥ 3 when asked to rate their sleep on an 11-point scale (0 is equivalent to no sleep disturbance and 10 is the worst possible sleep disturbance)~* Able to read English~* 21 years of age or older~Exclusion Criteria:~* No prior or concurrent regular (≥ 1 day/week) participation in yoga classes or maintain regular personal practice of any form of yoga within the past 3 months~* No diagnosis of sleep apnea~* No concurrent cancer therapy with the exception of hormonal therapy (e.g., tamoxifen citrate) or monoclonal antibodies (e.g., trastuzumab \[Herceptin®\])~* No metastatic cancer

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 120 Years
- Healthy Volunteers: f

Study Arms:
- Yoga Intervention (YOCAS) (Type: EXPERIMENTAL): Standardized Yoga for Cancer Survivors (YOCAS)
- Standard Care Control Condition (Type: EXPERIMENTAL): Standard follow-up care provided by their treating oncologists as appropriate for individual diagnoses.

Based on this trial design, predict the completion outcome and termination type (if applicable).